Published in Blood Transfus on January 01, 2015
Placenta-based therapies for the treatment of epidermolysis bullosa. Cytotherapy (2015) 0.79
Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol (2014) 3.05
Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment. J Am Acad Orthop Surg (2013) 2.65
TALEN-based gene correction for epidermolysis bullosa. Mol Ther (2013) 1.84
Strong evidence against platelet-rich plasma injections for chronic lateral epicondylar tendinopathy: a systematic review. Br J Sports Med (2014) 1.74
Platelets, inflammation and tissue regeneration. Thromb Haemost (2011) 1.69
PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia. Proc Natl Acad Sci U S A (2011) 1.38
Autologous platelet-rich plasma for treating chronic wounds. Cochrane Database Syst Rev (2012) 1.37
Platelet-rich therapies for musculoskeletal soft tissue injuries. Cochrane Database Syst Rev (2014) 1.30
Interventions for replacing missing teeth: augmentation procedures of the maxillary sinus. Cochrane Database Syst Rev (2014) 1.28
Use of platelet rich plasma gel on wound healing: a systematic review and meta-analysis. Eplasty (2011) 1.27
Platelet-rich plasma in dermatology: boon or a bane? Indian J Dermatol Venereol Leprol (2014) 1.09
Novel molecular therapies for heritable skin disorders. J Invest Dermatol (2011) 1.03
Platelet gel stimulates proliferation of human dermal fibroblasts in vitro. Acta Dermatovenerol Alp Pannonica Adriat (2007) 0.95
Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix. Lancet (2013) 0.94
Preliminary evaluation of cord blood platelet gel for the treatment of skin lesions in children with dystrophic epidermolysis bullosa. Blood Transfus (2014) 0.91
Which donor or graft source should you choose for the strongest GVL? Is there really any difference. Best Pract Res Clin Haematol (2013) 0.84
Serum levels of high mobility group box 1 correlate with disease severity in recessive dystrophic epidermolysis bullosa. Exp Dermatol (2013) 0.84
The use of platelet-rich plasma in the nonsurgical management of sports injuries: hype or hope? Hematology Am Soc Hematol Educ Program (2013) 0.83
Gene therapies for inherited skin disorders. Semin Cutan Med Surg (2014) 0.79
Editorial in response to the systematic review by de Vos et al: 'Strong evidence against platelet-rich plasma injections for chronic lateral epicondylar tendinopathy: a systematic review'. Br J Sports Med (2014) 0.78